Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Antibiotic Selection00:57

Antibiotic Selection

52.4K
Overview
52.4K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of risk-standardized metrics for benchmarking hospitals on their inpatient antibiotic use.

Infection control and hospital epidemiology·2026
Same author

DASC-LOT Framework and S3 Metric: A Novel Evaluation and Benchmarking Method to Assess Initiation, Duration, and Spectrum of Antimicrobial Usage at Inpatient Hospital Settings.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Underutilization of an Objective Vascular Screening Test in Patients with Diabetic Foot Ulcers.

Annals of vascular surgery·2026
Same author

Integrating Entrustable Professional Activities in Simulation-Based Health Care Education: A Systematic Literature Review.

Simulation in healthcare : journal of the Society for Simulation in Healthcare·2026
Same author

Genotypes of Hepatitis B and D Viruses Among Patients With Hepatitis D in the United States.

Journal of viral hepatitis·2026
Same author

Antibiotic stewardship practices at community living centers for veterans.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same journal

Suicidal Ideation and the Wider Value of Structured Care in Major Depression-Before the Near Miss.

JAMA network open·2026
Same journal

Interval Salpingectomy-Can We Have It All?

JAMA network open·2026
Same journal

What Patients Want From AI-Drafted Portal Messages-Empathy in the In-Basket.

JAMA network open·2026
Same journal

Hospital-Based Psychosocial Case Management and Suicide Prevention in South Korea: A Randomized Clinical Trial.

JAMA network open·2026
Same journal

Incidence of Recurrent Invasive Pneumococcal Disease in Canada.

JAMA network open·2026
Same journal

Opioid Use and Pain Resolution for Acute Pain Among Opioid-Naive Patients.

JAMA network open·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
09:59

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance

Published on: July 21, 2023

1.2K

Metrics Selection and Risk Adjustment Methods to Benchmark Inpatient Antibiotic Use.

Michihiko Goto1,2, Hyunkeun Cho1,3, James A Merchant1,4

  • 1Center for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs (VA) Health Care System, Iowa City.

JAMA Network Open
|June 11, 2025
PubMed
Summary
This summary is machine-generated.

Risk adjustment models for hospital antibiotic use significantly change benchmarking results when patient-level factors are included. These findings highlight the need for more comprehensive models in antimicrobial stewardship programs.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Related Experiment Videos

Last Updated: Jun 15, 2025

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
09:59

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance

Published on: July 21, 2023

1.2K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Area of Science:

  • Health Services Research
  • Infectious Diseases
  • Health Informatics

Background:

  • The Centers for Disease Control and Prevention's standardized antimicrobial administration ratio (SAAR) is used for hospital antibiotic use benchmarking.
  • Current SAAR models do not account for healthcare data's hierarchical nature or patient-level factors, potentially limiting stewardship efforts.

Purpose of the Study:

  • To evaluate antimicrobial use risk adjustment methods in hospital benchmarking.
  • To compare basic metrics like days of therapy (DOT) and days of antimicrobial spectrum coverage (DASC) in hospital benchmarking.

Main Methods:

  • Retrospective cohort study of 736,810 patients across 117 Veterans Health Administration (VHA) acute care hospitals (2021-2023).
  • Compared three benchmarking methods: unadjusted, risk adjustment with hospital/unit factors (Method 1), and risk adjustment with hospital/unit/patient factors (Method 2).
  • Utilized negative binomial and hierarchical zero-inflated negative binomial regression models.

Main Results:

  • Significant variability in unadjusted antibiotic use (DOT and DASC) was observed across hospitals.
  • Risk adjustment methods (Method 1 and Method 2) led to moderate changes in hospital rankings.
  • Weak correlations were found between benchmarking results from Method 1 and Method 2 (τB = 0.43 for DOT, 0.44 for DASC).

Conclusions:

  • Substantial differences in risk-adjusted benchmarking results exist between models using only hospital/unit factors versus those including patient-level factors.
  • Models incorporating patient-level data may offer higher content validity for assessing hospital and stewardship program performance.
  • Further research is needed to validate these more comprehensive models and their utility for informing antimicrobial stewardship.